Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin
Emerging Growth Conference
SOUTH SAN FRANCISCO, Calif., July 03, 2007/PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. todayannounced that Eric Bjerkholt,
Sunesis' Senior Vice President,Corporate Development and Finance, will present a company update atthe C. E. Unterberg, Towbin Emerging Growth Conference on July 12,2007 at 9:00 a.m. Eastern Time in New York, NY. Interested parties may access the webc...
Sunesis Pharmaceuticals Reports Positive Data From Studies of Two
Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of
the European Hematology Association
Interim Data from Phase 1 Clinical Trial of SNS-595 in AcuteLeukemia Demonstrates Additional Clinical Activity SOUTH SAN FRANCISCO, Calif., June 11, 2007/PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. presentedpositive data from clinical studies of two of the company'santi-cancer product candidates, SNS-595 and SNS-032, at the 12thCongress of the European Hematology Association (E...
Sunesis Pharmaceuticals to Present Data at the 12th Congress of the
European Hematology Association
SOUTH SAN FRANCISCO, Calif., June 01, 2007/PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. todayannounced that the company will present data from ongoing clinicalstudies of SNS-595 and SNS-032 at the 12th Congress of the EuropeanHematology Association (EHA) being held June 7-10, 2007 in Vienna,Austria. Presentations will include updated interim data from thecompany's Phase...
Sunesis Presents Data Supporting SNS-032's Potential Anticancer
Activity in Multiple Myeloma at the American Association for Cancer
Research Meeting
Results from Non-clinical Studies Confirm Mechanism of Action andProvide Guidance for Dosing SOUTH SAN FRANCISCO, April 16, 2007 /PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. presented non-clinical datademonstrating SNS-032's apoptotic activity in a multiple myelomamodel. These data were presented today in a poster session duringthe Annual Meeting of the American Association for...
Sunesis Pharmaceuticals to Present Data at the Annual Meeting of
the American Association for Cancer Research
SOUTH SAN FRANCISCO, Calif., April 13, 2007/PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. todayannounced that the company will present data at the Annual Meetingof the American Association for Cancer Research (AACR) being heldApril 14-18, 2007 in Los Angeles, California. Data being presented in a poster session will focus onnon-clinical data on SNS-032, a highly selective...
More>>